Mohammad M El-Metwally1,
Eman R ElBealy2,
Doha M Beltagy3,
Mohamed Shaaban4,
Attalla F El-kott5,6
For correspondence:- Attalla El-kott Email: elkottaf@yahoo.com
Accepted: 20 July 2020 Published: 31 August 2020
Citation: El-Metwally MM, ElBealy ER, Beltagy DM, Shaaban M, El-kott AF. Suppressive efficiency of Kojic acid from Aspergillus tamarii MM11 against HepG-2 cell line derived from human liver cancer. Trop J Pharm Res 2020; 19(8):1661-1668 doi: 10.4314/tjpr.v19i8.14
© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates